Compare Cytokinetics Inc (CYTK) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Old Dominion Freight Line Inc — how do they compare? Cytokinetics Inc trades at $61.95 (market cap $8.62B), while Old Dominion Freight Line Inc trades at $183.23 (market cap $37.68B). The key difference: Old Dominion Freight Line Inc is far larger — about 4.4× Cytokinetics Inc's market cap, and Old Dominion Freight Line Inc pays a 0.64% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Old Dominion Freight Line Inc for 76 Days on average.
| CYTK | ODFL | |
|---|---|---|
Market Cap | $8.62B | $37.68B |
Volume | 2,594,626 | 1,550,104 |
Sector | Health | Industrials |
52-Week High | $87.26 | $248.73 |
52-Week Low | $54.76 | $126.29 |
Typical Hold Time | 19 Days | 76 Days |
Enterprise Value | $8.72B | $37.42B |
Dividend Yield | — | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cytokinetics (CYTK) trades at $61.12, down 0.37% on the day, with a bearish technical signal from moving averages despite some oversold RSI readings. The company reported a net loss of $784.96 million on $88.04 million revenue in 2025, with a negative net income margin of -1,321.12% in 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy and executive stock sales.
Wall Street maintains strong bullish sentiment with a 97.14% buy rating and $112.60 consensus price target, but high cash burn, persistent losses, and insider selling pose significant risks. The stock's outlook hinges on successful commercialization of its heart failure pipeline amid substantial financial and competitive pressures.
Old Dominion Freight Line (ODFL) trades at $175.61, down 1.35% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.68 exceeding the $1.54 estimate. Revenue for 2025 was $5.50B, with a net income margin of 19.44%. A 4.9% general rate increase effective October 5, 2026, aims to support service investments amid cost pressures.
ODFL presents a mixed outlook; analyst consensus is a Buy with a $230.93 price target, implying significant upside, but technical indicators suggest near-term pressure. Risks include freight demand volatility and high valuation multiples. The stock's investment case hinges on execution of rate increases and sustained operational efficiency in a competitive trucking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
